Due to the beneficial effect of adiponectin on several diseases related to obesity, including diabetes, cardiac fibrosis, and a range of cancers, the pharmacological elevation of circulating adiponectin became the main interest of multiple research groups. The gene discussed is ADIPOQ; the disease is cancer.